Integrated Partnership With PharmaPros Dataflow Manager Enables New Functionality
FORT LAUDERDALE, Fla., June 25, 2012 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCBB:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced a new level of integration with PharmaPros that provides OmniComm customers with a solution offering next-generation CTMS capabilities for mid-sized organizations interested in a flexible, SaaS solution for clinical trials management. This new integrated solution provides capabilities for Site Management & Monitoring, Budget Tracking & Management, eTMF/Document Tracking, Metrics Portal & Real-time Reporting.
With access to these new tools, OmniComm customers can manage their clinical trial information in a more automated and scalable way. Connecting Trial Master EDC directly to Dataflow Manager through the OmniConnect web-based API eliminates the administrative burden of redundant data entry and reconciliation for clinical Sponsor and CRO organizations across a wide range of eClinical products, reducing trial costs, and providing significant workflow efficiencies.
"We are extremely pleased that OmniComm is now bundling Dataflow Manager's unique study management capabilities with their TrialMaster EDC product," said Brion Regan, Head of Strategic Development, PharmaPros. "We've already seen the benefits within our shared customer base, and have been impressed. OmniComm has proven to be a strong technology partner, with the ability to rapidly address the needs of their customers with value-driven solutions."
This integrated partnership enables OmniComm customers to add Dataflow Manager to their TrialMaster solution on an as-needed or per-trial basis. This flexibility gives customers the ability to quickly scale up or down, based on the needs of the trial, without costly and time-consuming implementations required by traditional CTMS solutions.
"We are excited about this new partnership and the benefits this marriage of EDC and CTMS will provide to our customers," said Stephen Johnson, President and COO of OmniComm. "This integrated partnership and solution is just one more example of how OmniComm is continuing to help our customers connect data across the eClinical spectrum."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.